Roscoe F. Morton

A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer

Richard M. Goldberg, Daniel J. Sargent, Roscoe F. Morton et al. · Journal of Clinical Oncology · 2003 · 2.3K citations

Medicine, Oncology, Pharmacology +15

Phase II Trial of Temsirolimus (CCI-779) in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study

Evanthia Galanis, Jan C. Buckner, Matthew J. Maurer et al. · Journal of Clinical Oncology · 2005 · 696 citations · Full text

Pharmacy, Oncology, Pharmacology +15

Phase II Trial of Single-Agent Temsirolimus (CCI-779) for Relapsed Mantle Cell Lymphoma

Thomas E. Witzig, Susan M. Geyer, Irene M. Ghobrial et al. · Journal of Clinical Oncology · 2005 · 520 citations

Medicine, Oncology, Pharmacology +17

Five-Year Data and Prognostic Factor Analysis of Oxaliplatin and Irinotecan Combinations for Advanced Colorectal Cancer: N9741

Hanna K. Sanoff, Daniel J. Sargent, Megan E. Campbell et al. · Journal of Clinical Oncology · 2008 · 306 citations · Full text

Medicine, Biostatistics, Oncology +12

Phase I/II Trial of Erlotinib and Temozolomide With Radiation Therapy in the Treatment of Newly Diagnosed Glioblastoma Multiforme: North Central Cancer Treatment Group Study N0177

Paul D. Brown, Sunil Krishnan, Jann N. Sarkaria et al. · Journal of Clinical Oncology · 2008 · 275 citations · Full text

Medicine, Oncology, Pharmacotherapy +17